The below linked article is from CenterWatch which
Post# of 72440
Quite a spread from the other site that claimed a 25-30% advancement rate after phase 3. Makes one scratch his/her head.
https://www.centerwatch.com/clinical-trials/overview.aspx/
https://www.centerwatch.com/